Extended-Spectrum Beta-Lactamases (ESBL)
- Extended-Spectrum Beta-Lactamases (ESBLs) are enzymes that can be produced by bacteria making them resistant to cephalosporins e.g. cefuroxime, cefotaxime and ceftazidime - which are the most widely used antibiotics in many hospitals
- ESBLs were first described in the mid-1980s and during the 1990s were mostly found in Klebsiella species, mostly in hospitals and often in intensive care units treating the most vulnerable patients
- a newer class of ESBL (called CTX-M enzymes) has emerged and these have been widely detected among Escherichia coli ( E. coli) bacteria
- these ESBL-producing E. coli are able to resist penicillins and cephalosporins and are found most often in urinary tract infections - though not simple cystitis
- have been found in the community as well as in hospitals, but patients with 'community acquired' infections may have had previous contact with hospitals
Reference:
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.